![Elliott Levy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elliott Levy
Director/Board Member at
OMEA THER
Net worth: 3 907 $ as of 2024-03-30
Profile
Elliott M.
Levy is the founder of Intrepid Alliance.
Current jobs include Independent Non-Executive Director at NuCana Plc since 2021, Independent Director at Omega Therapeutics, Inc. since 2021, Director at Kinaset Therapeutics, Inc., Venture Partner at 5AM Venture Management LLC since 2022, Senior Advisor at The Boston Consulting Group, and Media Contact at HeartFlow, Inc. Former jobs include Chairman at Transcelerate Biopharma, Inc. from 2017 to 2019, Independent Director at Editas Medicine, Inc. from 2023 to 2026, SVP-Strategy, Operations, Research & Development at Amgen, Inc. from 2020 to 2021, Senior Vice President & Head-Specialty Development at Bristol Myers Squibb Co. from 1997 to 2014, and Member-Renal Division at The Brigham & Women's Hospital, Inc. Education includes a doctorate from Yale School of Medicine conferred in 1987 and undergraduate studies at Yale College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NUCANA PLC 0.05% | 2026-06-18 | 15,026 ( 0.05% ) | 3 907 $ | 2024-03-30 |
| 2026-06-16 | 0 ( -.--% ) | - $ | 2026-07-30 |
Elliott Levy active positions
| Companies | Position | Start |
|---|---|---|
| OMEA THER | Director/Board Member | 2021-02-28 |
| NUCANA PLC | Director/Board Member | 2021-10-31 |
| HEARTFLOW, INC. | Public Communications Contact | - |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Private Equity Investor | 2021-12-31 |
The Boston Consulting Group | Consultant / Advisor | - |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Director/Board Member | - |
Former positions of Elliott Levy
| Companies | Position | End |
|---|---|---|
| EDITAS MEDICINE, INC. | Director/Board Member | 2026-08-03 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2021-04-30 |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Chairman | 2019-08-31 |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Elliott Levy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
HeartFlow, Inc.
 HeartFlow, Inc. Packaged SoftwareTechnology Services Develops and commercializes AI-powered cardiac imaging software | Technology Services |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Yale College
 Yale College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group | |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Health Technology |
- Stock Market
- Insiders
- Elliott Levy
